Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 densityTRANSLATIONAL PSYCHIATRYIF6.22023-10-194OAAI
Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and N-Acylethanolamines by Liquid Chromatography-Tandem Mass SpectrometryCANNABIS AND CANNABINOID RESEARCHIF2.72023-08-0110OAAI
Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J MiceCANNABIS AND CANNABINOID RESEARCHIF2.72020-03-0117OAAI
Different pharmaceutical preparations of Δ9-tetrahydrocannabinol differentially affect its behavioral effects in ratsADDICTION BIOLOGYIF2.62019-04-029PREAI
Familial abnormalities of endocannabinoid signaling in schizophrenia精神分裂症患者内源性大麻素信号的家族性异常WORLD JOURNAL OF BIOLOGICAL PSYCHIATRYIF3.82018-03-2230PREAI
Differential Association of Anandamide Levels with Binocular Depth Inversion Illusion Scores in SchizophreniaBIOLOGICAL PSYCHIATRYIF92017-05-011PREAI
Association of anandamide with altered binocular depth inversion illusion in schizophreniaWORLD JOURNAL OF BIOLOGICAL PSYCHIATRYIF3.82016-11-1125PREAI
Differential association of anandamide with binocular depth inversion in schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72014-10-010PREAI
MODULATION OF THE ENDOCANNABINOID SYSTEM AS A POTENTIAL NEW TARGET IN THE TREATMENT OF SCHIZOPHRENIASCHIZOPHRENIA RESEARCHIF3.52014-04-015PREAI
A TWIN STUDY ON ABNORMALITIES OF ENDOCANNABINOID FUNCTIONING IN SCHIZOPHRENIA AND BIPOLAR DISORDERSCHIZOPHRENIA RESEARCHIF3.52012-04-010PREAI
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaTRANSLATIONAL PSYCHIATRYIF6.22012-03-20832OAAI